Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pacira BioSciences Inc shares valued at $16,174 were sold by SLONIN JONATHAN on Jan 06 ’25. At $18.40 per share, SLONIN JONATHAN sold 879 shares. The insider’s holdings dropped to 93,444 shares worth approximately $2.45 million following the completion of this transaction.
Also, SLONIN JONATHAN purchased 879 shares, netting a total of over 16,174 in proceeds.
Before that, GAUGLER DARYL had sold 500 shares from its account. In a trade valued at $9,880, the Chief Operating Officer traded Pacira BioSciences Inc shares for $19.76 each. Upon closing the transaction, the insider’s holdings decreased to 500 shares, worth approximately $3.02 million.
As published in a research note from Truist on January 30, 2025, Pacira BioSciences Inc [PCRX] has been rated up from a Sell to a Hold and the price target has been revised to $25 from $8. Analysts at Truist downgraded the stock from ‘”a Buy”‘ to ‘”a Sell”‘ outlook in a report released in mid August. As of August 12, 2024, RBC Capital Mkts has decreased its “an Outperform” rating to a “Sector perform” for PCRX. Earlier on August 12, 2024, Raymond James downgraded its rating. Their new recommendation was “a Mkt perform” for PCRX stock which previously was a “an Outperform”.
Analyzing PCRX Stock Performance
During the last five days, there has been a surge of approximately 12.47%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 39.28%. Shares of the company reached a 52-week high of $27.59 on 01/30/25 and a 52-week low of $18.17 on 01/06/25. A 50-day SMA is recorded $19.83, while a 200-day SMA reached $20.73. Nevertheless, trading volume fell to 1.0 million shares from 0.98 million shares the previous day.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 25.41, which, if violated, would cause prices to drop to 24.58. In the upper region, resistance lies at 27.33. The next price resistance is at 28.42. RSI (Relative Strength Index) is 81.46 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.76, which suggests the price will increase in the coming days. Percent R is at 17.34%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
